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Vulval developmentThe conserved Mixed Lineage Leukaemia (MLL) complex deposits activating methyl marks on histone tails
through a methyltransferase (MT) activity. Here we provide in vivo evidence that in addition to methylation,
the C. elegans MLL-like complex can remove speciﬁc methyl marks linked to repression of transcription. This
supports the proposed model in which the MLL complex orchestrates both the deposition and the removal of
methyl marks to activate transcription. We have uncovered the MLL-like complex in a large-scale RNAi
screen designed to identify attenuators of RAS signalling during vulval development. We have also found
that the histone acetyltransferase complex, NuA4/TIP60, cooperates with the C. elegans MLL-like complex in
the attenuation of RAS signalling. Critically, we show that both complexes regulate a common novel target
and attenuator of RAS signalling, AJM-1 (Apical Junction Molecule-1). Therefore, the C. elegans MLL-like
complex cooperates with the NuA4/TIP60 complex to regulate the expression of a novel effector, AJM-1.Poulin).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Chromatin structure plays a critical role during development due
to its impact on the regulation of gene expression (Strahl and Allis,
2000). The structure adopted by the chromatin is highly inﬂuenced by
post-translational modiﬁcations such as phosphorylation, acetylation,
ubiquitination, and methylation (Kouzarides, 2007). Methylation of
histone tails is an important modiﬁcation, since it can regulate the
recruitment of additional chromatin complexes. For example, meth-
ylation of lysine 4 on histone H3 can recruit the ATP-dependent
nucleosome remodelling factor NURF to regulate transcription
activation (Sims and Reinberg, 2006; Wysocka et al., 2006), and
methylation at lysine 27 can recruit Polycomb to repress transcription
(Cao et al., 2005; Schuettengruber et al., 2007). These methylation
marks are crucial for the correct spatiotemporal expression of HOX
genes in mice (Soshnikova and Duboule, 2009), and are likely to play
an equivalent role for other key developmental genes (Azuara et al.,
2006; Bernstein et al., 2006).
The histone H3 lysine 4 (H3K4) trimethylation (me3) mark is
associated with activation of transcription, and can be deposited by
H3K4 methyltransferases (MTs) of the Mixed Lineage Leukaemia
(MLL) family (Ruthenburg et al., 2007). On the other hand, the
H3K27me3 mark correlates with repression of transcription (Cao
et al., 2002) and can be removed by H3K27 demethylases (DMs)(Agger et al., 2007; Cloos et al., 2008; Hong et al., 2007; Jepsen et al.,
2007; Lan et al., 2007; Lee et al., 2007; Swigut and Wysocka, 2007).
The identiﬁcation of UTX during the biochemical puriﬁcation of MLL2
(Issaeva et al., 2007) led to the suggestion that H3K27DMs could
function in association with the MLL complex (Cho et al., 2007; De
Santa et al., 2007). However, the in vivo evidence that H3K27DMs are
functionally associated with the MLL complex is limited (Agger et al.,
2007; Lan et al., 2007; Lee et al., 2007; Soshnikova and Duboule, 2008;
Swigut and Wysocka, 2007; Wysocka et al., 2005). Nevertheless, it is
an attractive possibility that the MLL complex, in addition to
sustaining transcription, could relieve repression. For this reason,
the MLL complex may stand at the apex of the molecular machinery
that determines gene expression in many processes, such as stem cell
development, cell cycle, segmental identity, hematopoiesis and the
inﬂammation response (Bernstein et al., 2006; De Santa et al., 2007;
Martinez and Cavalli, 2006; Mikkelsen et al., 2007; Okuda et al., 1996;
Wang et al., 2008; Yu et al., 1995).
In humans, there are at least six H3K4MTs of the MLL family
(MLL1-4, and SET1a and b) (Ruthenburg et al., 2007), and three
H3K27DMs of the JmjC family (UTX, UTY, and JMJD3) (Cloos et al.,
2008). TheMLL complex also includes the core complex (ASH2,WDR5
and RbBP5) that presents histone tails to H3K4MTs.
The C. elegans vulva system has been instrumental to identify and
characterise components of multiple core signalling pathways,
notably of the conserved EGFR/RAS/RAF/MAPK signalling pathway
(Fig. 1) (Sternberg, 2005). It has also shed light on the molecular
mechanisms involved in attenuation of RAS signalling (Sundaram,
2006). Chromatin remodelling complexes have been shown to play an
143K. Fisher et al. / Developmental Biology 341 (2010) 142–153important role in the process of attenuation, notably via regulation of
EGF expression (Cui et al., 2006) and regulation of negative or positive
modulators of the RAS signalling cascade (Berset et al., 2005; Shaye
and Greenwald, 2002; Singh and Han, 1995; Yoo et al., 2004).
Herein,we have performed a large-scale RNAi screen in a sensitised
genetic background (gap-1) to reveal attenuators of the RAS signalling
pathway (Fig. 1). This functional strategy has identiﬁed 39 candidates,
including most of the components of the C. elegansMLL complex. We
show that the MLL complex attenuates LET-60 RAS signalling. In
addition,we have found that depletion of the histone acetyltransferase
complex, NuA4/TIP60 (Ceol and Horvitz, 2004), has the same effect
as depleting the MLL complex. Interestingly, we have uncovered a
novel common target, AJM-1 (Apical Junction Molecule-1). AJM-1
is important to maintain the integrity of epithelial cell junctions
(Chisholm and Hardin, 2005; Koppen et al., 2001; Labouesse, 2006).Fig. 1. Cell fate speciﬁcation during vulval development. A) LIN-3 EGF is the inductive signal r
LET-60 RAS/LIN-45 RAF/MPK-1MAPK signalling pathway by binding to its receptor, LET-23 E
(VPCs: P5.p to P7.p) will acquire sufﬁcient LET-60 RAS signalling levels to adopt the vulval
rounds of cell divisions, except for two cells that will not proceed through the third divisio
(primary cells) express higher levels of LET-60 RAS signalling than their ﬂanking cells (se
syncytial cell hyp7 (black nuclei), and are thought to express a basal level of LET-60 RAS sign
LET-60 RAS signalling control vulval fate adoption. Mutants that decrease LET-60 RAS signal
phenotype. Mutants that increase LET-60 RAS signalling promote adoption of vulval fate in V
and produce the Muv phenotype (Ferguson et al., 1987; Sternberg, 2005; Sternberg and Horv
vulval fate (see Materials and methods). C) The LET-60 RAS/LIN-45 RAF/MPK-1 MAPK sig
Protein). In the absence of GAP-1, RAS remains bound to GTP (active form) for longer (Sun
cells. The primary cells (blue nucleus) produce the highest level of LET-60 RAS signalling,
expression of Notch ligands (Chen and Greenwald, 2004). The secondary cells (green nucl
signalling pathway (Sternberg, 2005; Sundaram, 2005). Numerous attenuators of LET-60 R
tertiary cells (white nucleus) are farther from the source of the ligand, and are thought toImportantly, AJM-1 also attenuates LET-60 RAS signalling, and hence
acts as a novel downstream effector of the MLL and NuA4/TIP60
complexes. Collectively, these results support a model whereby
the MLL complex cooperates with the NuA4/TIP60 complex to
attenuate LET-60 RAS signalling via epigenetic regulation of ajm-1
expression.
Materials and methods
Strains and general maintenance
Strains used in this study were: N2, gap-1(ga133), rrf-3(pk1426);
gap-1(ga133), lin-15A(n767), lin-15B(n744), let-60(n2021), let-60
(n2021);lin-15B(n744), let-60(n2021);lin-15A(n767), let-23(sy1);him-5
(e1490), unc-4(e120);arIs92[egl-17p::CFP::lacZ,unc-4(+),ttx-3p::GFP],equired for vulval fate adoption. It emanates from the anchor cell (AC) and activates the
GFR (Hill and Sternberg, 1992; Kimble, 1981). Three out of the six vulval precursor cells
fate (green and blue cells) (Sundaram, 2005). These three VPCs will go through three
n (black cells), generating the 22-cell vulva (Sulston and Horvitz, 1977). The blue cells
condary cells, green cells). The VPCs that do not adopt the vulval fate will fuse to the
alling (Aroian et al., 1990; Han et al., 1990; Han and Sternberg, 1990). B) Thresholds of
ling have less than three VPCs adopting the vulval fate and produce the Vulvaless (Vul)
PCs that would normally fuse to hyp7, hence they have more than three VPCs induced
itz, 1986, 1991). The number in parentheses indicates the number of VPCs adopting the
nalling cascade is conserved in VPCs and is attenuated by GAP-1 (GTPase Activating
daram, 2006). D) Different LET-60 RAS levels in primary, secondary and tertiary vulval
because they receive more inductive signal, LIN-3 EGF, which will also stimulate the
eus) receive less inductive signal, and are in addition attenuated by the LIN-12 Notch
AS are activated by LIN-12 Notch signalling (Berset et al., 2001; Yoo et al., 2004). The
produce only a basal level of LET-60 RAS signalling.
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(e1490);dels4[dpy-20(+)+ajm-1::GFP+lin-39TX::GFP (yeast DNA)],
pha-1(e2123), dpy-5(e907);sEx13557[rCesT12D8.1(set-16)::GFP+
pCeh361], mys-1(n4075)/nT1[qIs51], tag-125(ok1417), unc-119(ed3)
qaIs5 (Ex35[set-2::gfp+unc119(+)]),tag-125(ok1417);unc-4(e120);
arIs92[egl-17p::CFP::lacZ, unc-4 (+), ttx-3p::GFP], pha-1(e2123) ukEx1
[set-16p::GFP, pha-1(+)], him-5(e1490)bxIs13[egl-5::GFP], and lin-12
(n137n460). Strains were maintained as described in Brenner (1974).
RNAi experiments
The initial large-scale RNAi screen of chromosomes I, II and III was
performed similarly to that described previously (Kamath et al.,
2003). Brieﬂy, individual cultures were used to inoculate a single well
on a six-well plate (Poulin et al., 2005), between 4 and 8 synchronised
rrf-3(pk1426);gap-1(ga133) L3–L4 stage worms were placed in each
well and the plates were maintained at 20 °C. The F1 progeny were
scored for the Mvp (multiple ventral protrusion) phenotype. RNAi
clones causing N10% Mvp were selected for further analysis. 909 RNAi
clones produced a very weak Mvp phenotype. This was considered
a background that may reﬂect a weak genetic interaction between
gap-1 and rrf-3. RNAi experiments using high conﬁdence candidate
clones were repeated initially using the gap-1(ga133) mutant strain,
and were performed essentially as described above except that P0
mothers were transferred when they started to lay eggs fromwell1 to
well2 and the next day from well2 to well3. All RNAi clones were
obtained from the Ahringer RNAi library (Kamath et al., 2003) with
the exception of the ash-2 and mes-2 RNAi clones that are from the
Vidal library (Rual et al., 2004). All positive RNAi clones were veriﬁed
by sequencing.
Vulval induction assay
Early L4 stage worms were mounted on 2% (w/v) agarose pads in
20 mM tetramisole (Sigma) and the vulva cell lineage was scored as
described previously (Poulin et al., 2005; Sternberg and Horvitz,
1986).
Quantitative RT-PCR
RNAi for quantitative RT-PCR experiments was performed essen-
tially as described above with a few modiﬁcations. For L4440 empty
vector (RNAi) and lin-15A(RNAi) experiments ∼1000 synchronised L3
staged lin-15B(n744) worms were placed on RNAi plates seeded with
the respective RNAi clone. Worms fed set-16(RNAi) become partially
sterile and so ∼3000 synchronised L3 staged lin-15B(n744) worms
were used. The P0 mothers were washed off the plates and bleached
once they had been on RNAi for ∼54 h. The eggs were placed directly
back onto RNAi plates seededwith the appropriate RNAi clone and the
F1 worms harvested after 48 h. Total RNA was extracted using TRIzol
(Invitrogen) and ﬁrst strand cDNA synthesis was performed using the
Superscript VILO cDNA Synthesis Kit (Invitrogen), according to the
manufacturer's instructions. Quantitative RT-PCR was performed
using the FastStart SYBR Green Master (ROX) mix (Roche) on an
ABI Prism 7000 (Applied Biosystems). Three biological samples for
each RNAi condition were prepared, and for every biological replicate
a duplicate of 2 serial dilutions was analysed. act-1 was used as the
internal reference for data normalisation. lin-3 levels were deter-
mined by comparing the unknown samples to a standard curve of
known relative amounts.
Microinjection
To obtain the transgenic SET-16MLL::GFP strain, a 5.7 kb fragment
(5 kb upstream to 0.7 kb downstream of the starting ATG) was cloned
using Gateway® (Invitrogen) into pSB_GW::GFP. Following this100 µg/ml of this construct along with 10 µg/ml pha-1(+) (Granato
et al., 1994) was microinjected into the temperature sensitive mutant
pha-1(e2123) using the method previously described (Mello et al.,
1991).
GFP assays
RNAi experiments for GFP analysis were performed as described
above, by transferring the worms. ajm-1::GFP analysis was performed
using mid to late L4 hermaphrodites, egl-5::GFP analysis was
performed using young adult males and analysis of egl-17::CFP
expression was performed as described (Yoo et al., 2004).
Western blot analysis
RNAi was performed as described above. Whole worm protein
extracts were prepared by initially removing the P0 mothers from the
ﬁnal RNAi transfer well, and then harvesting the F1 worms. A
minimum volume of 20 µl pelleted worms was collected for each
protein sample, washed in PBS buffer, boiled in 2× Sample buffer
containing 100 mM DTT and sonicated. Antibodies against actin and
histone H3 were used for normalisation. To ensure that the blot was
performed within a linear range, we loaded serial two fold dilutions.
We used anti-H3K4me3 (Abcam ab8580); anti-H3 (Abcam ab1791);
anti-H3K27me3 (Upstate 07-449); and anti-actin (Abcam ab14128).
Detection was performed using the ECL Plus Western blotting
detection system according to the manufacturer's instructions
(Amersham Biosciences).
Immunostaining
RNAi was performed as described above. Brieﬂy, immunostaining
was performed using the freeze crack method (see Wormbook).
About 100 worms per well were mounted on 0.3% poly-lysine coated
three-well printed slides, methanol ﬁxed for 15 min, and washed
using PBS-Tween 0.2%. For staining, the slides were incubated with
MH27, a mousemonoclonal antibody speciﬁc to AJM-1, at a dilution of
1:75 in PBS-Tween 0.2% at 4 °C overnight. Following several washes,
slides were incubated with DyLight 594-conjugated AfﬁniPure Goat
Anti-mouse secondary antibody (Jackson ImmunoResearch cat. 115-
515-146) at 1:100, for 4 h at 37 °C.
Methylation assay
A C-terminal construct of SET-16 (residues Glu 2346 to Asn 2519)
was sub-cloned into the GST fusion vector pTHREE-E for bacterial
expression. The protein was isolated from the cell lysate on GST
afﬁnity resin (GE Healthcare), the tag was cleaved and the construct
was puriﬁed to homogeneity by gel ﬁltration. The puriﬁcation buffer
was 50 mM Tris–HCl, pH 7.5, 500 mMNaCl, 2 mM 2-mercaptoethanol
and 10% v/v glycerol. Methyltransferase assays were carried out as
described in Xiao et al. (2005). Brieﬂy, the puriﬁed enzyme (25 µM)
was incubated with 0.5 mM S-adenosyl-L-methionine (SAM),
0.625 µM 3H-SAM (GE Healthcare), and 1 mM H3 peptide substrate;
sequence ARTQTARYKSTGGKAPRY (University of Bristol). The incor-
poration of SAM was followed by separating the peptide from the
unincorporated 3H-SAM using “Sep Pak” C18 cartridges (Waters). The
ﬁnal salt concentration in the assays was 100 mM NaCl.
Results
Depletion of the MLL complex in the gap-1 background increases the
number of VPCs adopting the vulval fate
In order to identify genes involved in attenuation of LET-60 RAS
signalling, we performed a large-scale RNAi screen in a gap-1 (GTPase
145K. Fisher et al. / Developmental Biology 341 (2010) 142–153Activating Protein-1) mutant background. Deletion of gap-1 enhances
the activity of LET-60 RAS and thereby creates a hypersensitive
background for LET-60 RAS signalling, without affecting normal vulva
development (Hajnal et al., 1997). Only the loss of an additional
attenuator will produce a change in cell fate speciﬁcation (Yoo et al.,
2004).
To enable high throughput RNAi, we scored for Multiple ventral
protrusions (Mvp). The Mvp phenotype, visible under a dissecting
scope, can be caused by either migration defects or changes in cell
fate, the latter suggesting excessive LET-60 RAS signalling. To
distinguish between these two, we performed in vivo lineage analysis
that allows us to assign the Multivulvae (Muv) phenotype, which
corresponds to a change in cell fate speciﬁcation. The stereotypical
development of the vulva allows us to assign a score that corresponds
to the number of Vulval Precursor Cells (VPCs) adopting the vulval
fate (Fig. 1). A score of three is normal, greater than three is Muv, and
lower than three is Vulvaless (Vul) (Fig. 1 and Sternberg and Horvitz
(1986)).
Our RNAi screen covered the predicted genes from Chromosomes
I, II, and III, roughly representing 40% of the C. elegans genome
(Kamath et al., 2003). We have identiﬁed 39 genes producing theMvp
phenotype (Gutierrez and Fisher et al., unpublished data) and focused
our work on genes homologous to MLL, RbBP5, WDR5, and ASH2 (see
Table 1 for nomenclature). All these were identiﬁed during the screen
except for ash-2 that was not represented in the Ahringer library. We
have performed lineage analysis of the vulva after separate RNAi of
set-16 mll, rbbp-5,wdr-5, or ash-2 in the N2 wild type background. We
did not detect any animals producing the Muv phenotype. However,
we have found a signiﬁcant percentage of Muv animals when the
same experiment was performed in the gap-1 null background
(Fig. 2A). Therefore, set-16 mll and the core complex interact
genetically with gap-1 to produce a synthetic Muv phenotype.
Recently, it has been suggested that H3K27DMs could function
within the MLL complex (Agger et al., 2007; Cho et al., 2007; Issaeva
et al., 2007; Lan et al., 2007; Lee et al., 2007). To test this, we
inactivated by RNAi four predicted H3K27DMs (all on chromosome X)
in the gap-1 background and screened for Mvp animals. Animals
depleted of the UTX homologue, utx-1, produced the Mvp phenotype.
These utx-1(RNAi); gap-1 animals were therefore further analysed and
found to produce the Muv phenotype (Fig. 2A). utx-1(RNAi) in the
wild type background shows a low frequency of Muv animals, which
is increased ﬁve fold when the RNAi experiment is performed in the
gap-1 background (Fig. 2A). These results show that both SET-16 MLL
and UTX-1 are involved in preventing erroneous adoption of the
vulval fate.
SET-16 MLL and UTX-1 regulate H3K4 trimethylation and H3K27
demethylation, respectively
We addressed whether SET-16 MLL and UTX-1 are required for
trimethylation of H3K4 and demethylation of H3K27, respectively.
We performedWestern blots and found that there is less H3K4me3 in
set-16(RNAi) animals (about 35% decrease) compared to control gfp
(RNAi) animals, whilst no signiﬁcant difference was observed with
utx-1(RNAi) (Fig. 2B). Further, there is more H3K27me3 in utx-1Table 1
The C. elegans MLL complex.
C. elegans main name C. elegans seq. name Human homologue
set-16 T12D8.1 MLL2/3
utx-1 D2021.1 UTX
rbbp-5 F21H12.1 RBBP5
wdr-5a C14B1.4 WDR5
ash-2 Y17G7B.2 ASH2
a wdr-5 is also known as swd-3.(RNAi) animals compared to control animals (about 65% increase)
(Fig. 2C). To control the validity of our approach, we used extracts
from mes-2(RNAi) animals. MES-2 is a homologue of EZH2 and a
known H3K27MT (Ketel et al., 2005). Inmes-2(RNAi) animals there is
less H3K27me3 compared to control (30% decrease), whilst no
signiﬁcant difference was observed in set-16(RNAi) animals
(Fig. 2C). We have also performed a quantitative analysis of
H3K4me3 levels using extracts from the balanced set-16 mll knock
out and found about 25% less H3K4me3 than in N2 worms
(Supplementary Fig. 1). Therefore, SET-16 MLL and UTX-1 regulate
H3K4 methylation and H3K27 demethylation, respectively.
Trimethylation levels on H3K4 and H3K27 can toggle independently
An inverse correlation between H3K4me3 and H3K27me3 levels
has been documented in the HOX gene clusters (Agger et al., 2007;
Lan et al., 2007; Lee et al., 2007; Soshnikova and Duboule, 2009), but
our global analysis suggests that low levels of H3K4me3 caused by the
depletion of SET-16 MLL do not impact on H3K27me3 levels and vice
versa, since depletion of UTX-1 does not affect H3K4me3 (Figs. 2B and
C). This apparent discrepancy prompted us to test whether a wdr-5
deletion mutant shown to have reduced levels of H3K4me3 (Simonet
et al., 2007), would affect H3K27me3 levels. We observed the
reported reduction in levels of H3K4me3 (Fig. 2D), but the levels of
H3K27me3 remained unaffected (Fig. 2E). This suggests that WDR-5
is required for the trimethylation of H3K4, but not for the
demethylation of H3K27me3. Using the same reasoning but testing
the converse, we used mes-2/+ animals, in which H3K27me3 levels
are reduced (about 50%) (Fig. 2E), and found no alteration in
H3K4me3 levels (Fig. 2D). Therefore, we conclude that globally, levels
of H3K4me3 can be altered without affecting the levels of H3K27me3,
and vice versa.
SET-16 MLL is an H3K4MT
An analysis of the SET-16 sequence indicates that it is a member of
the Set1/trithorax/MLL (KMT2) family of H3K4 methyltransferases.
However, a more detailed analysis indicates that it most closely
resembles the SET domain of human MLL2 (Fig. 3A). Indeed when the
domain architecture of the full length proteins are considered SET-16
shares the organisation of the human MLL2/3 and the Drosophila TRR
proteins (Fig. 3B) with characteristic adjacent FY-rich domains and
lacking the taspase 1 recognition motif. In addition to SET-16 the only
other member of the KMT2 family is SET-2 (Simonet et al., 2007).
Sequence analysis and domain architecture indicates that this is the
worm homologue of the Set1/Set1A/B protein (Figs. 3A and B). In
C. elegans only one MLL-like protein, SET-16, and one Set1 protein,
SET-2, are required for H3K4 mediated transcriptional regulation.
To conﬁrm that SET-16 is an H3K4 methyltransferase we puriﬁed
from bacteria the C-terminal SET domain and two small predicted
helices representing the N-ﬂanking domain. Methyltransferase assays
were carried out with histone peptides which were either unmodiﬁed
or mono- or di-methylated at the K4 site (Fig. 3C). Robust activity was
observed with the unmodiﬁed peptide indicating that the isolated
domain has basal H3K4 monomethylase activity. We presume that as
has been seen for the MLL1 isolated SET domain, SET-16 will require
its cognate complex for activation and regulation (Southall et al.,
2009). These results show that SET-16 MLL is an H3K4MT.
SET-16 MLL is expressed in all VPCs
Histone methyltransferases such as SET-16 and SET-2 are pre-
dicted to have broad patterns of expression, but since we uncovered a
new function for SET-16 MLL during vulval development, we decided
to examine closely its pattern of expression in this tissue. We found a
high level of expression in the non-vulval descendants of the VPCs
Fig. 2. Both SET-16 MLL and UTX-1 are functional components of the MLL complex. A) TheMLL complex genetically interacts with gap-1 to produce the Muv phenotype. RNAi of set-
16 mll, rbbp-5, wdr-5, and ash-2 in N2 worms produce animals with a wild type vulva. Inactivation by RNAi of theMLL complex in the gap-1 background produces the synthetic Muv
phenotype. Number of animals analysed is indicated on the right, with the average number of VPCs induced in Muv animals. B) and C) SET-16 MLL and UTX-1 are required to
maintain appropriate levels of H3K4me3 and H3K27me3, respectively. Western blot analysis using antibody against H3K4me3 or H3K27me3 performed with protein extracts from
RNAi treated animals or mutants. At least three biological replicates were used. Data represented as mean±SEM. D and E) WDR-5 regulates global H3K4me3 levels, but not
H3K27me3 levels. Experiments performed as above.
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Fig. 3. SET-16 is the C. elegans homologue of human MLL2/3. A) Multiple sequence alignment of the SET domains from SET-16 and SET-2 with the human MLL1, MLL-2 and Set1A.
Residues identical in all ﬁve sequences are shown in bold with a blue background, residues common to MLL1 or MLL2 are shown with a pale blue background and residues common
to Set1A and SET-2 with a grey background. B) Domain organisation of SET-16 compared to the H3K4 methyltransferases in yeast, Drosophila and human. Like TRR, MLL2 and MLL3
the SET-16 protein has adjacent FYRN and FYRC domains and lacks taspase 1 recognition sequences. C) Methyltransferase activity of the isolated SET domain from SET-16 with
histone H3K4 peptide substrate, either unmodiﬁed or carrying H3K4 mono-methyl or di-methyl modiﬁcations. D) SET-16 MLL and SET-2 have a complementary pattern of
expression. Transgenic worms from a transcriptional fusion of SET-16 to GFP and a translational fusion of SET-2 to GFP were analysed for expression in VPCs' descendants after
second division (see Fig. 1).
147K. Fisher et al. / Developmental Biology 341 (2010) 142–153(vulval precursor cells) and a low level of expression in the vulval
cells (Fig. 3D, SET-16 MLL::GFP). We also looked at the expression of
SET-2::GFP, the other H3K4MT in C. elegans (Simonet et al., 2007),
even though set-2 does not appear to interact with gap-1 (Fig. 2A).We
found that it is expressed in all VPCs, as reported (Simonet et al.,
2007). We also noticed that SET-2::GFP expression is higher in the
VPCs that will give rise to vulval cells, and lower in the non-vulval
descendants. Hence, it appears that SET-16 MLL and SET-2 patterns of
expression are complementary (Fig. 3D, SET-2::GFP). The SET-16 MLLpattern of expression correlates with its function as an attenuator of
LET-60 RAS signalling. It is highly expressed in cells that have only
basal level of LET-60 RAS signalling, and expressed at a low level in
cells where LET-60 RAS signalling reaches higher levels.
SET-16 MLL synMuv activity requires LET-60 RAS signalling
The synthetic Muv (synMuv) genes prevent inappropriate adop-
tion of vulval fate. They can be divided into three classes A, B, and C.
148 K. Fisher et al. / Developmental Biology 341 (2010) 142–153Only double mutants between each class produce the Muv phenotype
(Fay and Yochem, 2007). Synthetic Muv interactions between gap-1
and synMuv genes have been previously characterised (Ceol et al.,
2006), suggesting that the MLL complex might also produce synMuv
interactions. We tested this by performing set-16 mll(RNAi) in lin-15A
(synMuv A), lin-15B (synMuv B), and mys-1 (synMuv C) mutants,
covering all three synMuv classes (Fay and Yochem, 2007). We
detected the Muv phenotype in all synMuv backgrounds (Fig. 4A),
suggesting that the MLL complex forms a promiscuous class of
synMuv genes. Potential genetic interactions with synMuv genes have
been tested in a previous study (Andersen and Horvitz, 2007), but the
lethality of the set-16 allele used precluded the vulval phenotype,
which is bypassed here by our RNAi conditions (Supplementary
Fig. 2).
The synMuv phenotype between A, B, and C has been shown to
depend on LET-60 RAS signalling (Fay and Yochem, 2007; Ferguson
et al., 1987; Huang et al., 1994; Lu and Horvitz, 1998; Poulin et al.,
2005). Hence, we testedwhether the SET-16MLL synMuv activity also
depends on LET-60 RAS signalling by using double mutants of
a reduced function allele of let-60 ras (let-60 rasrf) and lin-15A or
lin-15B. In both double mutants let-60 rasrf suppressed the synMuv
phenotype (Fig. 3A). We conclude that the synMuv activity of the MLL
complex is dependent on LET-60 RAS signalling.
The MLL complex and the NuA4/TIP60 complex can attenuate LET-60
RAS signalling in a wild type background
We next addressed whether the MLL complex could attenuate
LET-60 RAS signalling in vivo without additional mutations such as in
gap-1 or synMuv backgrounds. This ‘non-redundant’ activity can
be measured using a reporter system (Yoo et al., 2004). In this assay,
egl-17::cfp expression is detected in the daughter and granddaughter
cells of the VPCs expressing high levels of LET-60 RAS signalling
(Fig. 1D). In wild type, only the descendants of P6.p express egl-17::
cfp; the descendants of P5.p and P7.p (ﬂanking secondary cells) are
egl-17::cfp negative due to the low levels of LET-60 RAS signalling
(Figs. 1 and 4B) (Yoo et al., 2004).
We ﬁrst monitored the levels of LET-60 RAS signalling when
representative synMuv genes were absent (lin-15A (class A), lin-15B
(class B),mys-1 and trr-1 (class C)). Mutants for lin-15A or lin-15B did
not show persistent egl-17::cfp expression. In contrast, depletion of
mys-1 or trr-1 (components of the NuA4/TIP60) caused persistent
expression of egl-17::cfp in secondary cells (Fig. 4C). We next
performed separate RNAi of all the components of the MLL complex
and found that all can cause persistent expression of egl-17::cfp
(Figs. 4B and C). Therefore, the MLL complex and the NuA4/TIP60
complex can attenuate LET-60 RAS signalling in a wild type
background.
Excessive LET-60 Ras signalling is detected without an increase of lin-3
egf expression
An increase in LET-60 RAS signalling can be attributed to ectopic
expression of lin-3 egf (Andersen and Horvitz, 2007; Cui et al., 2006) or
extra anchor cell production (Phillips et al., 2007; Welchman et al.,
2007). Since an excess of LET-60 RAS signalling is detected in set-16 mll
(RNAi) animals (Fig. 4C), we tested whether ectopic expression of lin-3
egf could explain this effect. Using quantitative RT-PCR, we could not
detect any signiﬁcant changes in lin-3 egf expression between set-16mll
(RNAi) animals and gfp(RNAi) animals, even though the double mutant
lin-15AB showed an increase in lin-3 egf expression (Supplementary
Fig. 3) (Cui et al., 2006). Since synMuv inactivations cause ectopic
expression of lin-3 egf (Cui et al., 2006), we tested whether in a synMuv
context the double inactivation lin-15B and set-16 mll could affect lin-3
egf expression.Wecould not detect any difference in lin-3 egf expression
compared to the negative control (Fig. 4D).Next, we tested whether a somatic gonadal defect that can
sometimes cause extra anchor cell production could explain excessive
LET-60 RAS signalling observed in the absence of set-16mll.We assessed
the number of anchor cells produced when the MLL complex was
depleted using a transgenic strain carrying twomarkers: zmp-1::yfp and
egl-17::cfp (Welchman et al., 2007). zmp-1::yfp is an anchor cell marker,
whereas egl-17::cfp allowsus to conﬁrmexcessive LET-60RAS signalling.
We consistently observed only one anchor cell in animals depleted of
set-16 mll (data not shown).
It has also been reported that VPCs can be a source of LIN-3 EGF
(Dutt et al., 2004). We tested whether speciﬁc lin-3 RNAi in VPCs (as
described by Dutt et al.) could affect persistent expression of egl-17::
cfp in the absence of set-16 mll. Persistent egl-17::cfp remains similar
to set-16(RNAi) indicating that LIN-3 EGF from the VPCs is not
involved in this process (Fig. 4C). Taken together, these results
strongly suggest that excessive LET-60 RAS signalling is not caused by
ectopic expression of lin-3 egf or production of multiple anchor cells.The MLL complex and the NuA4/TIP60 complex regulate the expression
of an apical junction marker, AJM-1 (Apical Junction Molecule-1)
The mammalian MLL complex has been shown to regulate
expression of hox genes (Guenther et al., 2005; Milne et al., 2002;
Milne et al., 2005; Schuettengruber et al., 2007; Yu et al., 1995). We
hypothesised that hox genes may also be regulated by the C. elegans
MLL complex, and tested the effect of set-16 mll and utx-1 depletion
on two hox genes: egl-5 and lin-39. We could only detect an effect on
egl-5::gfp expression in males (see Supplementary Fig. 4).
Interestingly, the lin-39::gfp strain additionally carries an integrat-
ed epithelial cell marker, ajm-1::gfp (Fig. 5B, no RNAi). AJM-1 is
localised at the apical side of the vulval cells and whilst assessing the
effect of depleting SET-16 MLL on lin-39::gfp worms, we noticed the
disappearance of ajm-1::gfp expression (Fig. 5B). We further charac-
terised this effect using a different ajm-1::gfp transgenic strain that
does not carry the lin-39::gfp transgene (see Materials and methods).
Control animals expressed ajm-1 in the vulva at L4 stage (22-cell) as
previously described (Fig. 5A and Sharma-Kishore et al. (1999)). We
tested the effect of loss-of-function mutations of lin-15A or lin-15B.
Normal ajm-1::gfp expression was observed. However, inactivation by
RNAi of either set-16 mll or utx-1 prevented or strongly reduced ajm-1
expression (Fig. 5A). Interestingly, trr-1(RNAi), and mys-1(RNAi)
animals showed a similar defect (Fig. 5A). We veriﬁed these results
using a mys-1 mutant and observed a reduction in ajm-1::gfp
expression (Figs. 5A and B). Pharyngeal expression of ajm-1::gfp
was not affected (Supplementary Fig. 5). Importantly, regulation of
ajm-1::gfp expression by either the MLL complex or the NuA4/TIP60
complex is unrelated to the transgene integration site, since lin-39::
gfp expression is not affected and can therefore be considered an
internal control (Fig. 5B). This regulation is also not a general activity
of the synMuv genes, since lin-15A or lin-15B mutants did not reduce
ajm-1::gfp expression.
We next performed immunostaining against AJM-1 to verify that
the endogenous AJM-1 is also affected by the depletion of the MLL
complex. The control animals all show a speciﬁc staining in the vulval
cells at the ﬁrst division stage as well as in the pharynx (Sharma-
Kishore et al., 1999). In contrast, the set-16 (RNAi) animals express
AJM-1, but the staining appears thinner and fragmented (Fig. 5C). We
also performed the immunostaining at a later stage (after the second
division), in which the control animals show typical localisation of
AJM-1 in both the vulva and the pharynx. However, in set-16 (RNAi)
treated worms AJM-1 expression remains fragmented or even absent
in some cells (Fig. 5C). These experiments validate our observations
using the ajm-1::gfp transgene and strongly suggest that the MLL
complex and the NuA4/TIP60 complex act as positive regulators of
ajm-1 expression.
Fig. 4. TheMLL complex has redundant and non-redundant activities during vulva development. A) The redundant synMuv A, B and C genes genetically interact with set-16 mll. RNAi
of set-16 mll in either lin-15A (synMuv A), lin-15B (synMuv B) ormys-1 (synMuv C)mutants produce a synthetic Muv phenotype. The synMuv phenotype produced by either lin-15A;
set-16 mll(RNAi) or lin-15B;set-16 mll(RNAi) is suppressed by a let-60 RAS reduction-of-function mutation. Number of animals analysed is indicated on the right, with the average
number of VPCs induced in Muv animals. B) Non-redundant attenuation of LET-60 RAS signalling by the MLL complex. LET-60 RAS signalling levels were monitored using a reporter
(egl-17::cfp) sensitive to levels of LET-60 RAS signalling. Cells with high levels of RAS signalling will express CFP, but cells with low levels will not. Arrowheads point to the vulva cells
descendant of P5.p, P6.p and P7.p. C) The MLL and NuA4/TIP60 complexes are attenuators of LET-60 RAS signalling, but not LIN-15A or LIN-15B. Number of animals analysed
indicated on the right. * indicates that 27% of the population showed the absence of egl-17::cfp expression in VPCs. D) Levels of lin-3 egfmRNA remain unchanged in animals depleted
of set-16 mll in a lin-15B background. The positive control, lin-15B;lin-15A(RNAi), shows over expression of lin-3 egf.
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Fig. 5. The MLL and NuA4/TIP60 complexes regulate AJM-1 expression. Knock down of the MLL complex or the NuA4/TIP60 complex causes down regulation of AJM-1 expression.
A) Control animals exposed to the empty feeding vector, lin-15A, and lin-15B express normal levels of ajm-1::gfp. Animals exposed to RNAi targeting set-16 mll, utx-1, trr-1, ormys-1
as well as themys-1mutant lose AJM-1 expression to varying extents. B) Shown are representative pictures of the lin-39::gfp; ajm-1::gfp transgenic strain, and a DIC picture of the 22-
cell vulva. Control animals express lin-39::gfp in a gradient, and ajm-1::gfp as a punctate and polarised signal. set-16 mll(RNAi) does not affect lin-39::gfp expression, but the punctate
signal from ajm-1::gfp has disappeared. Also shown is the effect of mys-1 deletion on AJM-1 expression using a different ajm-1::gfp transgenic, but producing similar results. mys-1
heterozygote animals are not affected. C) SET-16 MLL regulates expression of endogenous AJM-1. Immunostaining using an antibody against AJM-1 shows that vulval AJM-1
expression is affected during knock down of set-16 mll. D) SET-16 MLL regulates mRNA levels of ajm-1. Progeny from a balanced set-16 mll strain express lower levels of ajm-1 than
the parental balanced strain with set-16 mll. E) RNAi of ajm-1 produces the synMuv phenotype in the gap-1 background, but not in a lin-12(n137n460) cold-sensitive gain-of-function
allele. Number of animals analysed is indicated on the right, with the average number of VPCs induced in Muv or Vul animals. F) AJM-1 can attenuate LET-60 RAS signalling similarly
to SET-16 MLL or GAP-1 (data taken from Fig. 3).
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Fig. 6. The MLL and NuA4/TIP60 complexes are part of a chromatin to signalling
pathway in which AJM-1 attenuates LET-60 RAS signalling. The MLL complex (in green)
regulates the deposition of the activating methyl mark on H3K4 (green circles) and the
removal of the repressive methyl mark on H3K27 (red circles). The combination of
these marks could lead to the recruitment of the NuA4/TIP60 complex (in blue), which
can augment histone tail acetylation and transcription rate. We postulate that these
post-translational modiﬁcations on histone tails are critical in transcriptional regulation
of ajm-1. Finally, AJM-1 (in red) attenuates LET-60 RAS signalling during vulval
development.
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We next addressed whether AJM-1 regulation is transcriptional
using quantitative RT-PCR. Since animals most affected by the loss of
SET-16 MLL do not reach the L3/L4 stages (see Supplementary Fig. 2),
we opted for embryos obtained from the set-16 mll balanced strain. Of
note, we could not detect an effect on ajm-1 expression using L4 set-16
(RNAi) animals. This is expected since ajm-1 expression in the
pharynx (a major site of ajm-1 expression) is not affected under
these conditions (Fig. 5C). We compared that strain with the
corresponding parental balanced strain and found that ajm-1 mRNA
levels, in the set-16 mll strain, are reduced by ∼50% (Fig. 5D). This
strongly suggests that SET-16 MLL regulates ajm-1 expression at the
level of transcription.
AJM-1 is an effector of the MLL complex and the NuA4/TIP60 complex
The identiﬁcation of AJM-1 as a shared target between the MLL
complex and the NuA4/TIP60 complex raised the question of whether
regulation of AJM-1 expression is biologically signiﬁcant. Since ajm-1
is on chromosome X and was not included in our screen, we tested
whether ajm-1(RNAi) could produce the Muv phenotype in the gap-1
background. Indeed, we found that ajm-1 interacts with gap-1 to
produce the Muv phenotype (Fig. 5E). Since AJM-1 is important for
integrity of epithelial junctions, we also tested whether ajm-1(RNAi)
could affect Notch signalling. Depletion of ajm-1 in a lin-12 gain-of-
function allele (Greenwald et al., 1983; Gupta et al., 2006; Komatsu
et al., 2008) did not increase the frequency of the Muv phenotype
(Fig. 5E). We next addressed whether excessive LET-60 RAS signalling
could be detected in animals depleted of ajm-1. We observed a
persistent expression of egl-17::cfp in 18% of the population (Fig. 5F).
The phenotypes observed in ajm-1(RNAi) animals compared to the
loss of the MLL complex or to the loss of the NuA4/TIP60 complex are
qualitatively comparable, suggesting that the regulation of ajm-1
expression is a biologically signiﬁcant process. Therefore, we propose
that AJM-1 is a novel downstream effector of both the MLL and NuA4/
TIP60 complexes.
Discussion
Using a large-scale RNAi screen and the vulva system we have
uncovered a C. elegansMLL-like complex that plays an important role
in attenuation of LET-60 RAS signalling.We demonstrate that both the
methyltransferase (SET-16 MLL) and the demethylase (UTX-1) of the
C. elegansMLL complex attenuate LET-60 RAS signalling. We have also
identiﬁed a novel target of the MLL complex, AJM-1. Critically, AJM-1
can prevent excessive LET-60 RAS signalling and act as a downstream
effector of the MLL complex. In addition, we found that the MLL
complex cooperates with the histone acetyltransferase complex,
NuA4/TIP60, to ensure appropriate levels of LET-60 RAS signalling.
Taken together, we have uncovered a novel chromatin to signalling
pathway in which the MLL complex and the NuA4/TIP60 complex
cooperate to attenuate LET-60 RAS signalling during vulva develop-
ment via positive regulation of a novel effector, AJM-1 (Fig. 6).
SET-16 MLL and UTX-1 are part of the C. elegans MLL complex
For the ﬁrst time a histonemethyltransferase and a demethylase of
the MLL complex have been studied side-by-side. We show that both
enzymes (SET-16 MLL and UTX-1) can prevent excessive LET-60 RAS
signalling via a common mechanism (positive regulation of AJM-1
expression), and ensure appropriate posterior expression of the hox
gene, egl-5. Based on these functional activities and on the
biochemical properties of both enzymes, we propose that SET-16
MLL and UTX-1 are components of a C. elegansMLL-like complex. This
will support the vertebrate model in which the MLL complex wouldorchestrate both deposition of the trimethyl (active) mark on H3K4,
and removal of the trimethyl (repressive) mark on H3K27 (Agger
et al., 2007; Cloos et al., 2008; Issaeva et al., 2007; Lan et al., 2007; Lee
et al., 2007).
Depletion of the MLL complex causes excessive LET-60 RAS signalling but
not over expression of lin-3 egf
We have identiﬁed the MLL complex through genetic interactions
with the known attenuator of the LET-60 RAS signalling pathway,
gap-1 (Ceol et al., 2006; Hajnal et al., 1997; Yoo et al., 2004). Other
synMuv genes are known to interact with gap-1, but the molecular
mechanism to produce that particular synMuv phenotype is still
unknown (Ceol et al., 2006). It is known, however, that doublemutants
between synMuv A and B genes cause over expression of lin-3 egf,
which promotes abnormal adoption of the vulval fate (Cui et al., 2006).
We have found that set-16 mll can interact with class A and B synMuv
genes, and therefore tested for over expression of lin-3 egf in this
context. We could not detect over expression of lin-3 egf. Even though
we cannot rule out that a small and undetectable amount of LIN-3 EGF
is sufﬁcient to cause the synMuv phenotype, it does suggest though
that other mechanisms are involved in the synMuv process.
AJM-1 is an effector of the MLL complex and the NuA4/TIP60 complex
Identiﬁcation of the genes regulated by the MLL complex can
indicate which biological function the complex is involved. From our
functional data, we expected that the MLL complex, and the NuA4/
TIP60 complex would have common targets. Interestingly, we have
found that AJM-1 is regulated by both the MLL complex, and the
NuA4/TIP60 complex. The role that AJM-1 plays during vulva
development has never been explored before this study. Surprisingly,
we have found that ajm-1(RNAi) produces the synMuv phenotype in
the gap-1 background, and causes excessive LET-60 RAS signalling in
our egl-17::cfp assay. These phenotypes are reminiscent of the
depletion of the MLL complex or of the NuA4/TIP60 complex.
Therefore, it is likely that AJM-1 is an effector of both the MLL, and
NuA4/TIP60 complexes. However, it is also likely that these
complexes additionally regulate other attenuators of the LET-60 RAS
signalling pathway. We predict that a number of these will interact
152 K. Fisher et al. / Developmental Biology 341 (2010) 142–153with gap-1 to produce the synMuv phenotype, and could be identiﬁed
in the future using our RNAi approach.
Concluding remarks
As hyperactivation of the RAS signalling cascade can lead to
uncontrolled proliferation, and even cancer development, it is therefore
important to decipher themechanisms that the cell employs to prevent
excessive RAS signalling. UsingRNAi technology and gap-1 as a sensitive
genetic background, we identiﬁed the MLL complex and the NuA4/
TIP60 complex in a novel chromatin to signalling pathway; these
complexes converge ontoAJM-1which in turn acts as a novel attenuator
of LET-60 RAS signalling (Fig. 6). Interestingly, the connection between
LET-60RAS signallingand theMLL complex inC. elegansmaybe relevant
to humans. Leukaemic patients harbouring MLL translocations and
mutated RAS have a very poor prognosis (Liang et al., 2006; Mahgoub
et al., 1998), and a synthetic lethal screen for interaction with the KRAS
oncogene has identiﬁed MLL (Luo et al., 2009).
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